Certain Factors Predict Psychological Outcomes in Cancer Survivors

This article originally appeared here.
Share this content:
Most Cancer Survivors Have Good Psychological Outcomes
Most Cancer Survivors Have Good Psychological Outcomes

(HealthDay News) -- Certain factors predict anxiety, depression, and comorbid anxiety-depression at one year in adult cancer survivors, according to research published online June 17 in the Journal of Clinical Oncology.

Allison W. Boyes, Ph.D., of the University of Newcastle in Callaghan, Australia, and colleagues recruited a sample of adult cancer survivors from two state-based cancer registries. A total of 1,154 participants completed self-report questionnaires at six and 12 months after diagnosis. The Hospital Anxiety and Depression Scale was used to assess anxiety and depression.

The researchers found similar prevalence of anxiety (about 20%), depression (13%), and comorbid anxiety-depression (9%) at 6 and 12 months. The most prevalent trajectory from 6 to 12 months for psychological morbidity was non-case for anxiety (70%), depression (82%), and comorbid anxiety-depression (87%). The strongest predictor for psychological morbidity at 12 months was psychological morbidity at 6 months. Other strong predictors of psychological morbidity included diagnosis of lung cancer and health risk behaviors, such as smoking and insufficient physical activity.

"In conclusion, between six and 12 months post-diagnosis, the majority of cancer survivors demonstrated a trajectory of psychological adjustment indicative of resilience or recovery," the authors write. "Earlier psychological morbidity, lung cancer diagnosis, a history of smoking, and inadequate physical activity were the strongest predictors of subsequent psychological morbidity."

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs